The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bifidobacteria Probiotic Market Research Report 2025
Synopsis
Bifidobacteria are a group of bacteria called probiotics that normally live in your intestines and stomach. They help your body perform essential functions such as digestion and staving off harmful bacteria.
Global Bifidobacteria Probiotic market is projected to reach US$ 172.7 million in 2029, increasing from US$ 137 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Bifidobacteria Probiotic market research.
The Bifidobacteria Probiotic Market refers to the industry involved in the production and distribution of probiotic products containing Bifidobacterium strains. Bifidobacteria are a type of beneficial bacteria that naturally reside in the human gastrointestinal tract and are known for their potential health benefits. Probiotics are live microorganisms that, when consumed in adequate amounts, provide health benefits to the host. Bifidobacteria strains are commonly used in probiotic supplements and foods due to their ability to support digestive health and boost the immune system. The market for Bifidobacteria probiotics has been expanding as consumers become more aware of the importance of gut health and seek natural ways to enhance their overall well-being. These products can come in various forms, including capsules, tablets, powders, and even added to food and beverages. Key drivers of the Bifidobacteria probiotic market include the growing interest in preventive healthcare, rising demand for natural and functional foods, and increasing research supporting the benefits of probiotics on gut health. The market is highly competitive, with numerous manufacturers and brands offering different formulations and probiotic strains. In addition to the consumer market, Bifidobacteria probiotics are also used in the pharmaceutical industry and in animal feed to promote gut health in livestock. The market outlook for Bifidobacteria probiotics is expected to remain positive as the interest in natural health products continues to grow, and scientific research further explores the potential benefits of these probiotic strains.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bifidobacteria Probiotic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BioGaia AB
Probi AB
DowDuPont Inc.
Nestlé S.A.
Procter & Gamble Company
Probiotics International Limite
Lallemand Inc
PharmaCare Laboratories
Dr. Willmar Schwabe Group
SymbioPharm GmbH
Pfizer
Incal Health
mitushi biopharma
Goerlich Pharma
Segment by Type
Dry
Liquid
Segment by Application
Hypermarket/Supermarket
Medical Stores
Specialty Stores
Online Stores
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Bifidobacteria Probiotic report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Bifidobacteria are a group of bacteria called probiotics that normally live in your intestines and stomach. They help your body perform essential functions such as digestion and staving off harmful bacteria.
Global Bifidobacteria Probiotic market is projected to reach US$ 172.7 million in 2029, increasing from US$ 137 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Bifidobacteria Probiotic market research.
The Bifidobacteria Probiotic Market refers to the industry involved in the production and distribution of probiotic products containing Bifidobacterium strains. Bifidobacteria are a type of beneficial bacteria that naturally reside in the human gastrointestinal tract and are known for their potential health benefits. Probiotics are live microorganisms that, when consumed in adequate amounts, provide health benefits to the host. Bifidobacteria strains are commonly used in probiotic supplements and foods due to their ability to support digestive health and boost the immune system. The market for Bifidobacteria probiotics has been expanding as consumers become more aware of the importance of gut health and seek natural ways to enhance their overall well-being. These products can come in various forms, including capsules, tablets, powders, and even added to food and beverages. Key drivers of the Bifidobacteria probiotic market include the growing interest in preventive healthcare, rising demand for natural and functional foods, and increasing research supporting the benefits of probiotics on gut health. The market is highly competitive, with numerous manufacturers and brands offering different formulations and probiotic strains. In addition to the consumer market, Bifidobacteria probiotics are also used in the pharmaceutical industry and in animal feed to promote gut health in livestock. The market outlook for Bifidobacteria probiotics is expected to remain positive as the interest in natural health products continues to grow, and scientific research further explores the potential benefits of these probiotic strains.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bifidobacteria Probiotic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BioGaia AB
Probi AB
DowDuPont Inc.
Nestlé S.A.
Procter & Gamble Company
Probiotics International Limite
Lallemand Inc
PharmaCare Laboratories
Dr. Willmar Schwabe Group
SymbioPharm GmbH
Pfizer
Incal Health
mitushi biopharma
Goerlich Pharma
Segment by Type
Dry
Liquid
Segment by Application
Hypermarket/Supermarket
Medical Stores
Specialty Stores
Online Stores
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Bifidobacteria Probiotic report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Bifidobacteria Probiotic Market Overview
1.1 Product Overview and Scope of Bifidobacteria Probiotic
1.2 Bifidobacteria Probiotic Segment by Type
1.2.1 Global Bifidobacteria Probiotic Market Value Comparison by Type (2023-2029)
1.2.2 Dry
1.2.3 Liquid
1.3 Bifidobacteria Probiotic Segment by Application
1.3.1 Global Bifidobacteria Probiotic Market Value by Application: (2023-2029)
1.3.2 Hypermarket/Supermarket
1.3.3 Medical Stores
1.3.4 Specialty Stores
1.3.5 Online Stores
1.4 Global Bifidobacteria Probiotic Market Size Estimates and Forecasts
1.4.1 Global Bifidobacteria Probiotic Revenue 2018-2029
1.4.2 Global Bifidobacteria Probiotic Sales 2018-2029
1.4.3 Global Bifidobacteria Probiotic Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bifidobacteria Probiotic Market Competition by Manufacturers
2.1 Global Bifidobacteria Probiotic Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bifidobacteria Probiotic Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bifidobacteria Probiotic Average Price by Manufacturers (2018-2023)
2.4 Global Bifidobacteria Probiotic Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bifidobacteria Probiotic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bifidobacteria Probiotic, Product Type & Application
2.7 Bifidobacteria Probiotic Market Competitive Situation and Trends
2.7.1 Bifidobacteria Probiotic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bifidobacteria Probiotic Players Market Share by Revenue
2.7.3 Global Bifidobacteria Probiotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bifidobacteria Probiotic Retrospective Market Scenario by Region
3.1 Global Bifidobacteria Probiotic Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bifidobacteria Probiotic Global Bifidobacteria Probiotic Sales by Region: 2018-2029
3.2.1 Global Bifidobacteria Probiotic Sales by Region: 2018-2023
3.2.2 Global Bifidobacteria Probiotic Sales by Region: 2024-2029
3.3 Global Bifidobacteria Probiotic Global Bifidobacteria Probiotic Revenue by Region: 2018-2029
3.3.1 Global Bifidobacteria Probiotic Revenue by Region: 2018-2023
3.3.2 Global Bifidobacteria Probiotic Revenue by Region: 2024-2029
3.4 North America Bifidobacteria Probiotic Market Facts & Figures by Country
3.4.1 North America Bifidobacteria Probiotic Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bifidobacteria Probiotic Sales by Country (2018-2029)
3.4.3 North America Bifidobacteria Probiotic Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bifidobacteria Probiotic Market Facts & Figures by Country
3.5.1 Europe Bifidobacteria Probiotic Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bifidobacteria Probiotic Sales by Country (2018-2029)
3.5.3 Europe Bifidobacteria Probiotic Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bifidobacteria Probiotic Market Facts & Figures by Country
3.6.1 Asia Pacific Bifidobacteria Probiotic Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bifidobacteria Probiotic Sales by Country (2018-2029)
3.6.3 Asia Pacific Bifidobacteria Probiotic Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bifidobacteria Probiotic Market Facts & Figures by Country
3.7.1 Latin America Bifidobacteria Probiotic Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bifidobacteria Probiotic Sales by Country (2018-2029)
3.7.3 Latin America Bifidobacteria Probiotic Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bifidobacteria Probiotic Market Facts & Figures by Country
3.8.1 Middle East and Africa Bifidobacteria Probiotic Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bifidobacteria Probiotic Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bifidobacteria Probiotic Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bifidobacteria Probiotic Sales by Type (2018-2029)
4.1.1 Global Bifidobacteria Probiotic Sales by Type (2018-2023)
4.1.2 Global Bifidobacteria Probiotic Sales by Type (2024-2029)
4.1.3 Global Bifidobacteria Probiotic Sales Market Share by Type (2018-2029)
4.2 Global Bifidobacteria Probiotic Revenue by Type (2018-2029)
4.2.1 Global Bifidobacteria Probiotic Revenue by Type (2018-2023)
4.2.2 Global Bifidobacteria Probiotic Revenue by Type (2024-2029)
4.2.3 Global Bifidobacteria Probiotic Revenue Market Share by Type (2018-2029)
4.3 Global Bifidobacteria Probiotic Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bifidobacteria Probiotic Sales by Application (2018-2029)
5.1.1 Global Bifidobacteria Probiotic Sales by Application (2018-2023)
5.1.2 Global Bifidobacteria Probiotic Sales by Application (2024-2029)
5.1.3 Global Bifidobacteria Probiotic Sales Market Share by Application (2018-2029)
5.2 Global Bifidobacteria Probiotic Revenue by Application (2018-2029)
5.2.1 Global Bifidobacteria Probiotic Revenue by Application (2018-2023)
5.2.2 Global Bifidobacteria Probiotic Revenue by Application (2024-2029)
5.2.3 Global Bifidobacteria Probiotic Revenue Market Share by Application (2018-2029)
5.3 Global Bifidobacteria Probiotic Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BioGaia AB
6.1.1 BioGaia AB Corporation Information
6.1.2 BioGaia AB Description and Business Overview
6.1.3 BioGaia AB Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BioGaia AB Bifidobacteria Probiotic Product Portfolio
6.1.5 BioGaia AB Recent Developments/Updates
6.2 Probi AB
6.2.1 Probi AB Corporation Information
6.2.2 Probi AB Description and Business Overview
6.2.3 Probi AB Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Probi AB Bifidobacteria Probiotic Product Portfolio
6.2.5 Probi AB Recent Developments/Updates
6.3 DowDuPont Inc.
6.3.1 DowDuPont Inc. Corporation Information
6.3.2 DowDuPont Inc. Description and Business Overview
6.3.3 DowDuPont Inc. Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.3.4 DowDuPont Inc. Bifidobacteria Probiotic Product Portfolio
6.3.5 DowDuPont Inc. Recent Developments/Updates
6.4 Nestlé S.A.
6.4.1 Nestlé S.A. Corporation Information
6.4.2 Nestlé S.A. Description and Business Overview
6.4.3 Nestlé S.A. Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nestlé S.A. Bifidobacteria Probiotic Product Portfolio
6.4.5 Nestlé S.A. Recent Developments/Updates
6.5 Procter & Gamble Company
6.5.1 Procter & Gamble Company Corporation Information
6.5.2 Procter & Gamble Company Description and Business Overview
6.5.3 Procter & Gamble Company Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Procter & Gamble Company Bifidobacteria Probiotic Product Portfolio
6.5.5 Procter & Gamble Company Recent Developments/Updates
6.6 Probiotics International Limite
6.6.1 Probiotics International Limite Corporation Information
6.6.2 Probiotics International Limite Description and Business Overview
6.6.3 Probiotics International Limite Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Probiotics International Limite Bifidobacteria Probiotic Product Portfolio
6.6.5 Probiotics International Limite Recent Developments/Updates
6.7 Lallemand Inc
6.6.1 Lallemand Inc Corporation Information
6.6.2 Lallemand Inc Description and Business Overview
6.6.3 Lallemand Inc Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lallemand Inc Bifidobacteria Probiotic Product Portfolio
6.7.5 Lallemand Inc Recent Developments/Updates
6.8 PharmaCare Laboratories
6.8.1 PharmaCare Laboratories Corporation Information
6.8.2 PharmaCare Laboratories Description and Business Overview
6.8.3 PharmaCare Laboratories Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.8.4 PharmaCare Laboratories Bifidobacteria Probiotic Product Portfolio
6.8.5 PharmaCare Laboratories Recent Developments/Updates
6.9 Dr. Willmar Schwabe Group
6.9.1 Dr. Willmar Schwabe Group Corporation Information
6.9.2 Dr. Willmar Schwabe Group Description and Business Overview
6.9.3 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Product Portfolio
6.9.5 Dr. Willmar Schwabe Group Recent Developments/Updates
6.10 SymbioPharm GmbH
6.10.1 SymbioPharm GmbH Corporation Information
6.10.2 SymbioPharm GmbH Description and Business Overview
6.10.3 SymbioPharm GmbH Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SymbioPharm GmbH Bifidobacteria Probiotic Product Portfolio
6.10.5 SymbioPharm GmbH Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Bifidobacteria Probiotic Description and Business Overview
6.11.3 Pfizer Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Pfizer Bifidobacteria Probiotic Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Incal Health
6.12.1 Incal Health Corporation Information
6.12.2 Incal Health Bifidobacteria Probiotic Description and Business Overview
6.12.3 Incal Health Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Incal Health Bifidobacteria Probiotic Product Portfolio
6.12.5 Incal Health Recent Developments/Updates
6.13 mitushi biopharma
6.13.1 mitushi biopharma Corporation Information
6.13.2 mitushi biopharma Bifidobacteria Probiotic Description and Business Overview
6.13.3 mitushi biopharma Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.13.4 mitushi biopharma Bifidobacteria Probiotic Product Portfolio
6.13.5 mitushi biopharma Recent Developments/Updates
6.14 Goerlich Pharma
6.14.1 Goerlich Pharma Corporation Information
6.14.2 Goerlich Pharma Bifidobacteria Probiotic Description and Business Overview
6.14.3 Goerlich Pharma Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Goerlich Pharma Bifidobacteria Probiotic Product Portfolio
6.14.5 Goerlich Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bifidobacteria Probiotic Industry Chain Analysis
7.2 Bifidobacteria Probiotic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bifidobacteria Probiotic Production Mode & Process
7.4 Bifidobacteria Probiotic Sales and Marketing
7.4.1 Bifidobacteria Probiotic Sales Channels
7.4.2 Bifidobacteria Probiotic Distributors
7.5 Bifidobacteria Probiotic Customers
8 Bifidobacteria Probiotic Market Dynamics
8.1 Bifidobacteria Probiotic Industry Trends
8.2 Bifidobacteria Probiotic Market Drivers
8.3 Bifidobacteria Probiotic Market Challenges
8.4 Bifidobacteria Probiotic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
